Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aytu BioScience, Inc.

2.32
+0.15006.91%
Post-market: 2.31-0.0100-0.43%19:26 EDT
Volume:246.52K
Turnover:560.32K
Market Cap:20.83M
PE:-2.78
High:2.37
Open:2.17
Low:2.15
Close:2.17
Loading ...
Feb 11, 2021

Major Issues Report

8-K - Current report
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Feb 08, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 25, 2021

Major Issues Report

8-K - Current report
Jan 06, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 21, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Dec 17, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 16, 2020

Major Issues Report

8-K - Current report
Dec 15, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 15, 2020

Major Issues Report

8-K - Current report
Dec 14, 2020

Major Issues Report

8-K - Current report
Dec 14, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 11, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Dec 10, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Dec 10, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 10, 2020

Major Issues Report

8-K - Current report
Dec 10, 2020

Major Issues Report

8-K - Current report
Dec 10, 2020

Business Combinations

425 - Prospectuses and communications, business combinations